Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150162 | SCV000197055 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Ala672Ala in exon 18 of AP3B1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 25.8% (1135/4406) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs42360). |
Prevention |
RCV000150162 | SCV000309770 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000363077 | SCV000458293 | benign | Hermansky-Pudlak syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001520309 | SCV001729373 | benign | Hermansky-Pudlak syndrome 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001689692 | SCV001907165 | benign | not provided | 2018-11-27 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000150162 | SCV004102209 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 46% of patients studied by a panel of primary immunodeficiencies. Number of patients: 44. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001689692 | SCV005302266 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome |
RCV001689692 | SCV002074576 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. |